Concepedia

Jim Slattery

JS

Statistics

Publications

52

Citations

12.5K

H-Index

32

Active since

1989

Affiliations

European Medicines Agency(Current)

Western General Hospital

Novartis (Switzerland)

Utrecht University

Universidad de Alcalá

Jim Slattery is an author at European Medicines Agency specializing in medicine, public health, and stroke.

ORCID

Top concepts

Publications per year

1989–2022

52

Publications

52

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Anders Olsson, John J.V. McMurray, G Thorgeirsson et al. · The Lancet · 1994 · 8.5K citations

, , +8

Is the EuroQol a Valid Measure of Health-Related Quality of Life After Stroke?

Paul Dorman, Fiona Waddell, Jim Slattery et al. · Stroke · 1997 · 276 citations

Atrial fibrillation and stroke: prevalence in different types of stroke and influence on early and long term prognosis (Oxfordshire community stroke project)

Peter Sandercock, John Bamford, Martin Dennis et al. · BMJ · 1992 · 253 citations · Full text

Evaluation of a stroke family care worker: results of a randomised controlled trial

Suzanne O’Rourke, Jim Slattery, T. Staniforth et al. · BMJ · 1997 · 230 citations

Qualitative Comparison of the Reliability of Health Status Assessments With the EuroQol and SF-36 Questionnaires After Stroke

Paul Dorman, Jim Slattery, Barbara Farrell et al. · Stroke · 1998 · 228 citations · Full text

, , +25

1–5 of 52